Annual optometry conference offers insights on clinical, practice challenges

Article

Optometrists nationwide were to pack up and head south to take part in the annual Optometry's Meeting at the Gaylord Palms Resort in Orlando, June 16-20.

Optometrists nationwide soon will pack up and head south to take part in the annual Optometry's Meeting at the Gaylord Palms Resort in Orlando, FL, June 16-20.

Optometry's Meeting blends the annual conferences of the American Optometric Association and the American Optometric Student Association. Other professional groups also convene during the 4-day event.

The meeting offers more than 200 hours of continuing education, featuring up to 30 hours of free CE. The keynote speaker is Frank Abagnale, an expert on forgery, embezzlement, and secure documents. The presidential celebration, sponsored by HOYA, will spotlight the comic duo of Frank Caliendo and John Pinette.

WEDNESDAY, JUNE 16:

THURSDAY, JUNE 17:

THURSDAY AND FRIDAY, JUNE 17 AND 18:

THURSDAY, JUNE 17:

FRIDAY JUNE 18:

SATURDAY, JUNE 19:

Recent Videos
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
© 2025 MJH Life Sciences

All rights reserved.